Home/Database/Vasoactive Intestinal Peptide
ImmuneClinical Trials

Vasoactive Intestinal Peptide

VIP (Vasoactive Intestinal Peptide)

28 Amino Acids · MW: 3,326.82 Da

Amino Acids

28

Molecular Weight

3,326.82 Da

Half-life

~1-2 minutes (plasma)

Research Score

4.3

Studies

300

Storage

-20°C lyophilized, 2-8°C reconstituted

What is Vasoactive Intestinal Peptide?

VIP is a 28-amino acid neuropeptide found throughout the body. It regulates smooth muscle activity, epithelial cell secretion, and blood flow. In recent years, it has gained attention for treating chronic inflammatory response syndrome (CIRS), mold illness, and neuroinflammation.

Key Benefits & Mechanisms

Regulates inflammatory cytokines

Treats CIRS and mold illness

Pulmonary artery vasodilation

Neuroprotective properties

Improves cognitive function in CIRS

Regulates TGF-beta and MMP-9

Supports gut function

Research Summary

VIP has moderate-to-strong preclinical and growing clinical evidence, with over 300 studies supporting its immunomodulatory and neuroprotective properties. Mechanistically, it binds the VPAC1/VPAC2 receptors to suppress pro-inflammatory cytokines (TNF-α, IL-6, IL-12), promote the anti-inflammatory cytokine IL-10, inhibit NF-κB signaling, modulate Th1/Th2 balance, and expand regulatory T cells. Clinically, the Dr. Ritchie Shoemaker intranasal protocol for chronic inflammatory response syndrome (CIRS)/mold illness is widely used in functional medicine, where VIP has demonstrated anti-inflammatory and neuroprotective effects and growing acceptance.